Nexalin Technology

Nexalin Technology

Medical Devices, 1776 Yorktown St, Houston, Texas, 77056, United States, 11-50 Employees

nexalin.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 83********

Who is NEXALIN TECHNOLOGY

Nexalin Technology is a non-invasive and drug-free therapy for those living with anxiety, depression and/or insomnia. Nexalins Patented Waveform (1 U.S. Patent #6904322B2) The Nexalin dev...

Read More

map
  • 1776 Yorktown St, Houston, Texas, 77056, United States Headquarters: 1776 Yorktown St, Houston, Texas, 77056, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • Mark White CEO:   Mark White

industries-icon Industry: Medical Devices

SIC SIC Code: 4911 | NAICS Code: 541511 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NEXALIN TECHNOLOGY

Nexalin Technology Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Nexalin Technology

Answer: Nexalin Technology's headquarters are located at 1776 Yorktown St, Houston, Texas, 77056, United States

Answer: Nexalin Technology's phone number is 83********

Answer: Nexalin Technology's official website is https://nexalin.com

Answer: Nexalin Technology's revenue is $10 Million to $25 Million

Answer: Nexalin Technology's SIC: 4911

Answer: Nexalin Technology's NAICS: 541511

Answer: Nexalin Technology has 11-50 employees

Answer: Nexalin Technology is in Medical Devices

Answer: Nexalin Technology contact info: Phone number: 83******** Website: https://nexalin.com

Answer: Nexalin Technology is a non-invasive and drug-free therapy for those living with anxiety, depression and/or insomnia. Nexalins Patented Waveform (1 U.S. Patent #6904322B2) The Nexalin device produces a patented waveform that provides Transcranial Electrical Stimulation (TES). In clinical trials, this unique waveform resulted in the greatest increase in beta-endorphins. The Nexalin device has undergone extensive safety analysis with the results clearly indicating that the device is safe for its intended use. Additionally, the FDA classification of the device for clinical trials places it into a non-significant risk (low risk device) category. Natural frequency will promote balance in the brain by normalizing neurochemistry.This effectiveness of this unique therapy is long lasting and FDA approved. Laboratory and clinical evidence suggest that Nexalins patented electrical stimulation affects the hypothalamus and related brain structures to adapt and change the levels of neurochemicals including neuropeptides, neurotransmitters, and neuromodulators. The clinical data suggests that the Nexalin electrical stimulation will move endocrine outputs toward normalization, specifically from the hypothalamic nuclei and associated brain structures. A key indicator of this is a significant clinical change in levels of enkephalins and beta-endorphins in the cerebral spinal fluid of Nexalin-treated subjects, as well as other neurochemicals like Serotonin and Dopamine.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access